-
公开(公告)号:WO2011154696A1
公开(公告)日:2011-12-15
申请号:PCT/GB2011/000863
申请日:2011-06-08
Applicant: CAMBRIDGE ENTERPRISE LIMITED , FUNXIONAL THERAPEUTICS LIMITED , GRAINGER, David, John , FOX, David John
Inventor: GRAINGER, David, John , FOX, David John
IPC: C07D211/56 , C07D223/12 , C07D401/12 , A61K31/4523 , A61K31/45 , A61K31/55 , A61P29/00 , A61P37/00 , A61P17/06
CPC classification number: C07D223/12 , C07D211/74 , C07D211/76 , C07D401/12
Abstract: Disclosed herein are methods of preventing or treating inflammatory diseases using 3 - aminolactam compounds, each with aromatic "tail groups". Compounds as defined by formulae (I) and (I'), and the medical uses of the compounds, are described herein.
Abstract translation: 本文公开了使用具有芳族“尾组”的3-氨基内酰胺化合物预防或治疗炎性疾病的方法。 本文描述了式(I)和(I')所定义的化合物以及化合物的医学用途。
-
2.
公开(公告)号:WO2008150256A1
公开(公告)日:2008-12-11
申请号:PCT/US2007/012804
申请日:2007-05-31
Applicant: CATERPILLAR INC. , MORROW, David, John , DESAI, Paresh, Remeshchandra , HILL, Stephen, Francis , GORDON PETER, Thomas Alexander , MCGOWAN, David, John , CHAMBERS, Keith, David Robert
Inventor: MORROW, David, John , DESAI, Paresh, Remeshchandra , HILL, Stephen, Francis , GORDON PETER, Thomas Alexander , MCGOWAN, David, John , CHAMBERS, Keith, David Robert
CPC classification number: H02J7/1476 , H02J7/1415 , H02P9/04 , H02P9/10 , H02P9/14
Abstract: A Gen-Set (10) control system is disclosed. The control system has an engine (12) having a desired operating range and a generator (14) driven by the engine to produce an electrical powe output. The control system also has an engine control module (30) communicatively coupled with the engine, and configured to change and operating parameter of the engine based on a load command before a load on the engine causes the engine to deviate from the desired operating range. The control system further has an automatic voltage regulator (32). The automatic voltage regulator is configured to monitor at least one of a voltage output, a current output, and a power factor of the generator and generate the load command based on a change in at least one of the voltage output, the current output, and the power factor. The automatic voltage regulator (32) is also configured to deliver the load command to the engine control module (30).
Abstract translation: 公开了Gen-Set(10)控制系统。 控制系统具有具有期望的操作范围的发动机(12)和由发动机驱动以产生电力输出的发电机(14)。 控制系统还具有与发动机通信地联接的发动机控制模块(30),并且被配置为在发动机上的负载使发动机偏离期望的操作范围之前基于负载命令改变和操作发动机的参数。 控制系统还具有自动电压调节器(32)。 自动电压调节器被配置为监视发电机的电压输出,电流输出和功率因数中的至少一个,并且基于电压输出,电流输出和 功率因数。 自动电压调节器(32)还被配置为将负载命令传送到发动机控制模块(30)。
-
公开(公告)号:WO2006024815A1
公开(公告)日:2006-03-09
申请号:PCT/GB2005/003134
申请日:2005-08-10
Applicant: CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED , GRAINGER, David, John , FOX, David, John
Inventor: GRAINGER, David, John , FOX, David, John
IPC: C07D453/06
CPC classification number: C07D225/02 , C07D207/273 , C07D211/76 , C07D223/12 , C07D487/08
Abstract: The invention relates to the generation of a library of compounds enriched in agonist and antagonists for members of the G-protein coupled class of receptors (GPCRs). The library contains compounds of general formula (I) wherein y is any integer from 1 to 8; z is one integer from 0 to 8 with the proviso that y and z cannot simultaneously be 1; X is -CO-(Y) k -(R 1 ) n or SO 2 -(Y) k -(R 1 ) n ; k is 0 or 1; y is a cycloalkyl or polycyloalkyl group (such as an adamantyl, adamantanemethyl, bicyclooctyl, cyclohexyl, cyclopropyl group); or y is a cycloalkenyl or polycycloalkenyl group; each R 1 is independently selected from hydrogen or an alkyl, haloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, alkylamino, alkylaminoalkyl, alkylaminodialkyl, charged alkylaminotrialkyl or charged alkylcarboxylate radical of 1 to 20 carbon atoms; or each R 1 is independently selected from fluoro, chloro, bromo, iodo, hydroxy, oxyalkyl, amino, aminoalkyl, aminodialkyl, charged aminotrialkyl, or carboxylate radical; and n is any integer from 1 to m, where m is the maximum number of substitutions permissible on the cyclo-group Y; or alternatively R 1 may be selected from a peptido radical, for example having from 1 to 4 peptidic moieties linked together by peptide bonds (for example a peptido radical of 1 to 4 amino acid residues).
Abstract translation: 本发明涉及产生富含G-蛋白偶联受体类(GPCR)成员的激动剂和拮抗剂的化合物文库。 该文库含有通式(I)的化合物,其中y为1至8的整数; z为0至8的整数,条件是y和z不能同时为1; X是-CO-(Y)
-
4.
公开(公告)号:WO2008150256A8
公开(公告)日:2009-04-02
申请号:PCT/US2007012804
申请日:2007-05-31
Applicant: CATERPILLAR INC , MORROW DAVID JOHN , DESAI PARESH RAMESHCHANDRA , HILL STEPHEN FRANCIS , GORDON PETER THOMAS ALEXANDER , MCGOWAN DAVID JOHN , CHAMBERS KEITH DAVID ROBERT
Inventor: MORROW DAVID JOHN , DESAI PARESH RAMESHCHANDRA , HILL STEPHEN FRANCIS , GORDON PETER THOMAS ALEXANDER , MCGOWAN DAVID JOHN , CHAMBERS KEITH DAVID ROBERT
CPC classification number: H02J7/1476 , H02J7/1415 , H02P9/04 , H02P9/10 , H02P9/14
Abstract: A Gen-Set (10) control system is disclosed. The control system has an engine (12) having a desired operating range and a generator (14) driven by the engine to produce an electrical power output. The control system also has an engine control module (30) communicatively coupled with the engine, and configured to change and operating parameter of the engine based on a load command before a load on the engine causes the engine to deviate from the desired operating range. The control system further has an automatic voltage regulator (32). The automatic voltage regulator is configured to monitor at least one of a voltage output, a current output, and a power factor of the generator and generate the load command based on a change in at least one of the voltage output, the current output, and the power factor. The automatic voltage regulator (32) is also configured to deliver the load command to the engine control module (30).
Abstract translation: 公开了Gen-Set(10)控制系统。 控制系统具有具有期望的操作范围的发动机(12)和由发动机驱动以产生电力输出的发电机(14)。 控制系统还具有与发动机通信地联接的发动机控制模块(30),并且被配置为在发动机上的负载使发动机偏离期望的操作范围之前基于负载命令改变和操作发动机的参数。 控制系统还具有自动电压调节器(32)。 自动电压调节器被配置为监视发电机的电压输出,电流输出和功率因数中的至少一个,并且基于电压输出,电流输出和 功率因数。 自动电压调节器(32)还被配置为将负载命令传送到发动机控制模块(30)。
-
公开(公告)号:WO2007020386A3
公开(公告)日:2007-04-05
申请号:PCT/GB2006002988
申请日:2006-08-09
Applicant: TCP INNOVATIONS LTD , GRAINGER DAVID JOHN , FOX DAVID JOHN
Inventor: GRAINGER DAVID JOHN , FOX DAVID JOHN
IPC: C07K5/11 , A61K38/02 , A61K38/07 , A61P17/06 , A61P25/16 , A61P25/28 , A61P29/00 , A61P35/00 , A61P37/06 , C07K7/02
Abstract: The invention provides low molecular weight apoE mimetic agents suitable for preparing a medicament to treat autoimmune, inflammatory or neurodegenerative disease, (X) a - L - (X) b (Formula (I)) wherein each X is a (potentially different) chemical moiety bearing a positive charge at physiological pH a and b are, independently, numbers between 3 and 6; and L is a linker.
Abstract translation: 本发明提供了适用于制备治疗自身免疫性,炎症性或神经退行性疾病的药物的低分子量apoE模拟剂,(X) - (X)B(式 (I)),其中每个X是在生理pH a和b处带有正电荷的(可能不同的)化学部分,独立地为3至6; 而L是连接体。
-
公开(公告)号:WO2006134384A1
公开(公告)日:2006-12-21
申请号:PCT/GB2006/002217
申请日:2006-06-14
Applicant: CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED , GRAINGER, David, John , FOX, David, John
Inventor: GRAINGER, David, John , FOX, David, John
IPC: A61K31/55 , C07D223/10 , A61P29/00 , A61K31/4015 , A61K31/45 , C07D211/76 , C07D207/26 , C07D225/02
CPC classification number: C07D223/12 , A61K31/4015 , A61K31/45 , A61K31/55 , C07D207/267 , C07D207/273 , C07D211/76
Abstract: The invention provides compounds, pharmaceutical compositions and uses of compounds and salts thereof of general formula (I), for the preparation of a medicament for treatment of an inflammatory disorder, but excluding (S)-3-(r-methylcyclohexylcarbonylamino)-caprolactam: wherein z is 1,2,3 or 4; A is -CO- or -SO2-; Q is linear or branched alkyl, alkenyl, alkynyl, alkoxy, oxyalkyl, aminoalkyl, akylamino, alklylaminoalkyl, haloalkyl, aryl or substituted aryl; T 1 and T 2 together constitute a cycloalkyl, cycloalkenyl or polycycloalkyl radical composed of n additional carbon atoms, where n is between 2 and 7; and each hydrogen atom bonded to the carbon atoms in the ring generated by T 1 and T 2 may be independently be substituted by a group R 1 , where R 1 is independently selected from an alkyl, haloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl or alkylamino radical of 1 to 20 carbon atoms; or each R 1 is independently selected from fluoro, chloro, bromo, iodo, hydroxy, oxyalkyl, amino, aminoalkyl or aminodialkyl radical.
Abstract translation: 本发明提供了通式(I)的化合物及其盐的化合物,药物组合物及其用途,用于制备治疗炎症性疾病但不包括(S)-3-(R-甲基环己基羰基氨基) - 己内酰胺的药物: 其中z为1,2,3或4; A是-CO-或-SO 2 - ; Q是直链或支链烷基,烯基,炔基,烷氧基,烷氧基,氨基烷基,烷基氨基,烷基氨基烷基,卤代烷基,芳基或取代的芳基; T 1和T 2一起构成由n个另外的碳原子组成的环烷基,环烯基或多环烷基,其中n在2和7之间; 并且与T 1和T 2所形成的环中的碳原子键合的每个氢原子可以独立地被基团R 1, 其中R 1独立地选自具有1至20个碳原子的烷基,卤代烷基,烷氧基,卤代烷氧基,烯基,炔基或烷基氨基; 或每个R 1独立地选自氟,氯,溴,碘,羟基,烷氧基,氨基,氨基烷基或氨基二烷基。
-
公开(公告)号:WO2005053702A3
公开(公告)日:2005-09-15
申请号:PCT/GB2004005030
申请日:2004-11-30
Applicant: UNIV CAMBRIDGE TECH , GRAINGER DAVID JOHN , FOX DAVID JOHN
Inventor: GRAINGER DAVID JOHN , FOX DAVID JOHN
CPC classification number: C07D223/12 , A61K31/55
Abstract: The invention relates to the use of 3-aminocaprolactam derivatives for preparing a medicament intended to prevent or treat inflammatory disorders, and uses compounds of general formula (I) or a pharmaceutically acceptable salts thereof; wherein X is -CO-R or-SO2-R , and R and R are carbonaceous substituents.
Abstract translation: 本发明涉及3-氨基己内酰胺衍生物用于制备预防或治疗炎症性疾病的药物的用途,并且使用通式(I)的化合物或其药学上可接受的盐; 其中X是-CO-R 1或-SO 2 -R 2,R 1和R 2是含碳取代基。
-
公开(公告)号:WO2005053702A2
公开(公告)日:2005-06-16
申请号:PCT/GB2004/005030
申请日:2004-11-30
Applicant: CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED , GRAINGER, David, John , FOX, David, John
Inventor: GRAINGER, David, John , FOX, David, John
IPC: A61K31/55
CPC classification number: C07D223/12 , A61K31/55 , Y02A50/411
Abstract: The invention relates to the use of 3-aminocaprolactam derivatives for preparing a medicament intended to prevent or treat inflammatory disorders, and uses compounds of general formula (I) or a pharmaceutically acceptable salts thereof; wherein X is -CO-R 1 or-S0 2 -R 2 , and R 1 and R 2 are carbonaceous substituents.
Abstract translation: 本发明涉及3-氨基己内酰胺衍生物用于制备预防或治疗炎症性疾病的药物的用途,并且使用通式(I)的化合物或其药学上可接受的盐; 其中X是-CO-R 1或-SO 2 -R 2,R 1和R 2是含碳取代基。
-
9.
公开(公告)号:WO2013091016A1
公开(公告)日:2013-06-27
申请号:PCT/AU2012/001587
申请日:2012-12-21
Applicant: CANON KABUSHIKI KAISHA , BATTLE, David John , MAUNDER, David John , BONE, Donald James
Inventor: BATTLE, David John , MAUNDER, David John , BONE, Donald James
IPC: G01B11/25
CPC classification number: G01B11/2513 , B25J9/1697 , G05B2219/37131
Abstract: Disclosed is a method of determining coordinates (790) of a reference point (780) on an object in three-dimensional space in a scene captured by an image sensor. The object is irradiated by light sources (710,720) which are modulated at a different spatio-temporal frequency. The method generates a composite phase signal (630,640) on the object by a predetermined geometric arrangement of the light sources, and captures (910) the composite phase signal at the reference point with the image sensor. A processing arrangement determines, from the captured composite phase signal, a set of measured positioning parameters (measured carrier phase ψ lm ) independent of a position of the image sensor. The measured positioning parameters from the light sources are used for determining the coordinates of the reference point.
Abstract translation: 公开了一种确定由图像传感器捕获的场景中的三维空间中的对象上的参考点(780)的坐标(790)的方法。 该物体被不同时空频率调制的光源(710,720)照射。 该方法通过光源的预定几何布置在物体上产生复合相位信号(630,640),并且利用图像传感器捕获(910)参考点处的复合相位信号。 处理装置从捕获的复合相位信号中确定独立于图像传感器的位置的一组测量的定位参数(测量的载波相位psilm)。 来自光源的测量的定位参数用于确定参考点的坐标。
-
公开(公告)号:WO2006018609A2
公开(公告)日:2006-02-23
申请号:PCT/GB2005/003139
申请日:2005-08-10
Applicant: CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED , GRAINGER, David, John , FOX, David, John
Inventor: GRAINGER, David, John , FOX, David, John
IPC: A61K31/439 , A61K31/55 , C07D453/06 , C07D487/08
CPC classification number: A61K31/55 , A61K31/439 , C07D451/14
Abstract: The invention provides compounds, compositions, and uses of compounds of general formula (I) or pharmaceutically acceptable salts thereof, for the preparation of a medicament intended to treat an inflammatory disorder wherein y is any integer from 1 to 8; z is any integer from 1 to 8; with the proviso that y and z cannot both equal 1; X is -C -(Y) k -(R 1 ) n or SO 2 -(Y) k (R 1 ) n ; k is 0 or 1; Y is a cycloalkyl or polycyloalkyl group (such as an adamantyl, adamantanemethyl, bicyclooctyl, cyclohexyl, cyclopropyl group); or Y is a cycloalkenyl or polycycloalkenyl group.
Abstract translation: 本发明提供了通式(I)化合物或其药学上可接受的盐在制备用于治疗炎性病症的药物中的化合物,组合物和用途,其中y是1的任何整数 到8; z是1至8中的任何整数; 条件是y和z不能等于1; X是-C-(Y)k-(R 1)n或SO 2 - (Y) (R 1 sup>) n sub>; k是0或1; Y为环烷基或多环烷基(如金刚烷基,金刚烷甲基,二环辛基,环己基,环丙基); 或Y是环烯基或多环烯基。 p>
-
-
-
-
-
-
-
-
-